Pharma Two B Company

Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.
Technology: Small Molecules
Industry: Geroscience
Headquarters: Rehovot, HaMerkaz, Israel
Founded Date: 2007-01-01
Employees Number: 1-10
Investors Number: 5
Total Funding: 38000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2017-02-27
Last Funding Type: Series C

Visit Website
http://www.pharma2b.com
Register and Claim Ownership